Sylogist Announces Renewal of its NCIB and Declares Quarterly Dividend

Core Viewpoint - Sylogist Ltd. has announced the approval of a Normal Course Issuer Bid (NCIB) by the Toronto Stock Exchange, effective February 19, 2026, to repurchase its common shares, believing that the market price may not reflect their intrinsic value, thus benefiting remaining shareholders [1]. Group 1: NCIB Details - As of February 5, 2026, Sylogist has 23,389,577 common shares outstanding, with 22,589,922 in public float. Under the NCIB, the company can repurchase up to 2,258,992 shares, which is 10% of the public float [2]. - The average daily trading volume for the six months prior to the NCIB was 66,437 shares, allowing a daily purchase limit of 16,609 shares under the NCIB [2]. - The NCIB will terminate on the earlier of February 18, 2027, or when the permitted purchases are completed, with Sylogist having the option to terminate it at any time [2]. Group 2: Previous NCIB - The current NCIB renews a previous bid where Sylogist was approved to purchase up to 2,258,532 shares, having completed the purchase of 19,100 shares at a weighted average price of $9.17 per share from November 28, 2024, to November 27, 2025 [3]. Group 3: Automatic Repurchase Plan - Sylogist has established an automatic repurchase plan (ASPP) with its designated broker to facilitate share purchases during predetermined blackout periods, while purchases outside these periods will be at management's discretion [4]. Group 4: Dividend Announcement - The Board of Directors has declared a dividend of $0.01 per share on its common shares, payable on March 11, 2026, to shareholders of record on February 28, 2026 [5].